Cavitation Technologies Reports Steep Losses, Cash Depletion, and Going Concern Warning

summarizeSummary

Cavitation Technologies, Inc. reported a significant net loss, a drastic reduction in cash, and a substantial stockholders' deficit, leading to a going concern warning and ineffective internal controls.

check_boxKey Events

• Going Concern Warning Issued

  Management explicitly stated substantial doubt about the company's ability to continue as a going concern within one year, with current cash reserves ($31,000 as of December 31, 2025) projected to sustain operations only through March 2026.

• Significant Financial Deterioration

  The company reported a net loss of $734,000 for the six months ended December 31, 2025, a sharp decline from a net income of $352,000 in the prior year period. Cash and cash equivalents plummeted from $249,000 to $31,000, and stockholders' equity shifted to a $248,000 deficit.

• Revenue Collapse

  Revenue for the three months ended December 31, 2025, was $0, representing a 100% decrease from $76,000 in the prior year period, primarily due to the prior year's patent assignment to Desmet.

• Ineffective Internal Controls

  Management concluded that disclosure controls and procedures were not effective as of December 31, 2025.

auto_awesomeAnalysis

Cavitation Technologies, Inc. is facing severe financial distress, as evidenced by a substantial net loss, a drastic reduction in cash, and a shift to a stockholders' deficit. The explicit 'going concern' warning, coupled with cash reserves only sufficient through March 2026, highlights an urgent need for additional financing. The complete collapse in revenue for the quarter and the disclosure of ineffective internal controls further compound the company's precarious position. Investors should be aware of the significant operational and financial risks, including potential further dilution or cessation of operations if new capital is not secured.